FIELD: organic chemistry, biochemistry, medicine.
SUBSTANCE: invention relates, in particular, to optionally N-oxidized compounds represented by the formula: wherein R1 represents hydrogen atom, (C1-C6)-alkyl group, phenyl group optionally substituted with halogen atom, (C1-C6)-alkylthio-group or (C1-C6)-alkylsulfonyl, or amino-group optionally substituted with (i) (C1-C6)-alkyl group or (ii) acyl group -(C=O)-R5 wherein R5 represents (C1-C6)-alkyl group, phenyl or pyridyl; R2 represents (C6-C14)-aryl group optionally substituted with halogen atom or (C1-C6)-alkoxy-group, or 5- or 6-membered aromatic heterocyclic group comprising one sulfur atom or one nitrogen atom; R3 represents phenyl group optionally substituted with one or two (C1-C6)-alkyl groups or (C1-C6)-alkoxy-group; X represents sulfur atom; Y represents oxygen (O), sulfur (S) atom or NR4 wherein R4 represents hydrogen atom or (C1-C6)-alkyl group; Z represents a bond, (C1-C6)-alkylene group optionally substituted with oxo-group or (C1-C6)-alkyl group. Compounds of the formula (I) or their salts elicit high inhibitory effect on p38 MAP kinase and inhibition in producing TNF-α and elicit antagonistic effect with respect to adenosine A3-receptor also and therefore they can be useful as prophylactic or medicinal agents used in treatment of diseases mediated by function of adenosine A3-receptor, cytokines or p38 MAP kinase.
EFFECT: valuable biological and medicinal properties of compounds.
38 cl, 8 tbl, 66 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PROPHYLAXIS AND TREATMENT OF NEUROPATHY | 2003 |
|
RU2337682C2 |
CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
N, N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REABSORPTION INHIBITORS | 2006 |
|
RU2414454C2 |
PYRIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | 2004 |
|
RU2353617C2 |
TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | 2007 |
|
RU2456278C2 |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
HETEROCYCLIC COMPOUNDS, METHOD OF PREPARATION THEREOF, COMPOSITION BASED THEREON AND METHOD OF COUNTERACTION AGAINST TACHYKININ RECEPTORS | 1994 |
|
RU2135471C1 |
HIV-INHIBITING 5-AMIDO-SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2480464C2 |
2-AMINOPYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THERAPY | 2001 |
|
RU2250898C2 |
SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUND, METHOD OF PHARMACOLOGICAL EFFECT, METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY, INHIBITION OF LIPID PEROXIDES PRODUCTION OR BLOOD SUGAR LEVEL DECREASE | 1998 |
|
RU2196141C2 |
Authors
Dates
2004-09-27—Published
2000-04-20—Filed